Tools commonly used in the Heart Disease Information & Treatment industry for day-to-day tasks and operations.

• Electrocardiogram (ECG)
• Echocardiogram
• Cardiac catheterization
• Angioplasty
• Stent placement
• Coronary artery bypass surgery
• Pacemaker
• Implantable cardioverter defibrillator (ICD)
• Blood pressure monitor
• Cholesterol-lowering medications
• Aspirin
• Beta blockers
• Calcium channel blockers
• ACE inhibitors
• Diuretics
• Nitroglycerin
• Statins
• Heart rate monitor
• Exercise equipment

Common products and services typical of NAICS Code 624190-49, illustrating the main business activities and contributions to the market.

• Cardiac rehabilitation programs
• Heart disease support groups
• Heart disease education classes
• Heart disease clinics
• Cardiology practices
• Heart disease research organizations
• Heart disease treatment centers
• Heart disease prevention programs
• Heart disease screening services
• Heart disease diagnostic services

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• American Board Of Internal Medicine (ABIM) Cardiovascular Disease Certification: This certification is for physicians who specialize in cardiovascular disease and have completed the necessary training and education. The certification is provided by the American Board of Internal Medicine (ABIM).
• Certified Cardiac Rehabilitation Professional (CCRP): This certification is for healthcare professionals who work in cardiac rehabilitation and have completed the necessary training and education. The certification is provided by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).
• Registered Cardiovascular Invasive Specialist (RCIS): This certification is for healthcare professionals who work in cardiovascular invasive procedures and have completed the necessary training and education. The certification is provided by Cardiovascular Credentialing International (CCI).
• Certified Cardiographic Technician (CCT): This certification is for healthcare professionals who perform electrocardiograms (ECGs) and have completed the necessary training and education. The certification is provided by Cardiovascular Credentialing International (CCI).
• Certified Cardiovascular Technologist (CVT): This certification is for healthcare professionals who work in cardiovascular technology and have completed the necessary training and education. The certification is provided by Cardiovascular Credentialing International (CCI).

A concise historical narrative of NAICS Code 624190-49 covering global milestones and recent developments within the United States.

• The history of the "Heart Disease Information & Treatment" industry dates back to the early 20th century when the first heart surgeries were performed. In 1896, Ludwig Rehn performed the first successful heart surgery by removing a knife from a patient's heart. In 1951, the first successful open-heart surgery was performed by Dr. F. John Lewis. In the 1960s, the first pacemaker was implanted, and in the 1970s, the first coronary artery bypass surgery was performed. In the United States, the American Heart Association was founded in 1924 to promote heart health and research. In 1948, the Framingham Heart Study began, which was a long-term study that identified risk factors for heart disease. In the 1980s, the first statin drugs were introduced to lower cholesterol levels, and in the 1990s, the first stents were used to keep arteries open. Today, the industry continues to advance with new treatments and technologies. In recent history, the "Heart Disease Information & Treatment" industry in the United States has seen significant advancements. In 2013, the American College of Cardiology and the American Heart Association released new guidelines for the treatment of cholesterol, which emphasized the use of statins. In 2015, the FDA approved a new class of cholesterol-lowering drugs called PCSK9 inhibitors. In 2016, the first leadless pacemaker was approved for use in the United States. In 2017, the FDA approved a new heart failure drug called Entresto. In 2019, the FDA approved a new transcatheter aortic valve replacement (TAVR) device for patients with severe aortic stenosis. These advancements have improved the treatment and outcomes for patients with heart disease in the United States.

The anticipated future trajectory of the NAICS 624190-49 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the "Heart Disease Information & Treatment" industry in the USA is positive. According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death in the United States, accounting for one in every four deaths. As the population ages, the demand for heart disease information and treatment is expected to increase. The industry is likely to benefit from advances in technology, such as telemedicine, which can improve access to care for patients in remote areas. Additionally, the industry is likely to benefit from increased public awareness of heart disease risk factors and prevention strategies. Overall, the industry is expected to experience steady growth in the coming years.

Recent groundbreaking advancements and milestones in the Heart Disease Information & Treatment industry, reflecting notable innovations that have reshaped its landscape.

• Wearable Technology: Wearable technology, such as smartwatches and fitness trackers, can monitor heart rate and other vital signs, providing patients with real-time information about their health.
• Telemedicine: Telemedicine allows patients to consult with healthcare providers remotely, improving access to care for patients in remote areas or those who are unable to travel to a healthcare facility.
• Genetic Testing: Genetic testing can identify individuals who are at increased risk of developing heart disease, allowing for early intervention and prevention.
• Artificial Intelligence: Artificial intelligence can be used to analyze large amounts of data, helping healthcare providers to identify patterns and develop personalized treatment plans for patients.
• Minimally Invasive Procedures: Minimally invasive procedures, such as angioplasty and stenting, can treat heart disease without the need for open-heart surgery, reducing recovery time and improving outcomes.